choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Irritable Bowel Syndrome Drugs

Irritable Bowel Syndrome Drugs Newsletter
  • Medicare Drug Prices Slashed for 2027—See the 15 on the List 27 Nov 2025 07:23 GMT

    … additional drugs in 2026. Below, we share which medications Medicare … know about the new Medicare drug prices  In 2022, … .  Trelegy Ellipta, an asthma treatment, will go from $654 to … .  Xifaxan, for diarrhea and irritable bowel syndrome, will go from $2, …

  • Medicare announces major drug price cuts, projected $12 billion savings by 2027 26 Nov 2025 23:48 GMT

    … ’s leukemia treatment Calquence, Boehringer Ingelheim’s lung drug Ofev, and … , and AbbVie’s Linzess for irritable bowel syndrome, down to $136 from $ … than 300 drugs. Negotiations for 15 additional drugs, including hospital-administered medications, are …

  • Latest round of Medicare prescription drug price cuts announced 26 Nov 2025 22:16 GMT

    … of price negotiations. The medications include the drugs Medicare spends the most … on, such as popular GLP-1 medications … and irritable bowel syndrome: $1,000, down from $2,696. Vraylar, an antipsychotic drug

  • Medicare unveils price reductions for 15 drugs, including Novo's semaglutide 26 Nov 2025 20:27 GMT

    … While pushing for lower drug prices through his Most … are two drugs from AbbVie. Antipsychotic treatment Vraylar was … to $770, while irritable bowel syndrome medicine Lynzess was adjusted … loss of coverage for medications and higher insurance premiums,” …

  • Trump administration says lower prices for 15 Medicare drugs will save taxpayers billions 26 Nov 2025 17:27 GMT

    … prices for 15 prescription drugs after months of negotiations … some of the prescription medications on which Medicare … arthritis drug; and various drugs that treat diabetes, irritable bowel syndrome and … paying for weight-loss treatments, but a separate …

  • The hidden epidemic of unexplained pain 29 Nov 2025 03:19 GMT

    … extensive testing, and try multiple treatments with limited relief. The consequences … complex disorders such as fibromyalgia, irritable bowel syndrome or migraine headaches. Others may … advance the awareness, diagnosis and treatment of stress-related, brain- …

  • Medicare’s 15-drug negotiation signals bigger savings ahead 26 Nov 2025 11:51 GMT

    … . AstraZeneca’s leukemia drug Calquence, Boehringer’s lung-disease treatment Ofev, and … price negotiations for 10 different drugs. “They are getting more efficient … $654 list price. AbbVie’s irritable bowel syndrome medication Linzess will fall to $136 …

  • Medicare announces lower prices for 15 drugs including Ozempic, Wegovy  26 Nov 2025 04:11 GMT

    drugs, including popular weight-loss medications Ozempic and Wegovy, asthma treatments and chemotherapy drugs … administration has previously announced drug price reductions through …  irritable bowel syndrome medicine Linzess will cost $136. List of drugs

  • Medicare announces price cuts for 15 prescription drugs, including Ozempic 26 Nov 2025 00:16 GMT

    … on 15 costly prescription drugs under Medicare, including … Trelegy Ellipta, an asthma treatment: $175, down from $654 … irritable bowel syndrome: $1,000, down from $2,696. Vraylar, an antipsychotic drug … Medicare Part D covers medications that people take at …

  • <![CDATA[Medicare Set to Unveil Prices for 15 High-Cost Drugs ]]> 25 Nov 2025 19:56 GMT

    … most expensive prescription meds under Medicare—a … encephalopathy recurrence in adults, irritable bowel syndrome with diarrhea) Vraylar ( … Medicaid spending on prescription drugs was over $100 … Drug Costs and Expand Access to Affordable Medications.  …

Satisfied with the content?

Continue to create your account.